Open AccessCurrent evidence for the risk of PR prolongation, QRS widening, QT prolongation, from lopinavir, ritonavir, atazanavir, and saquinavir
Author(s) -
Denio Adrianus Ridjab,
Ignatius Ivan,
Fanny Budiman,
Dwi Jani Juliawati
Publication year - 2021
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000026787
Subject(s) - saquinavir , ritonavir , atazanavir , medicine , lopinavir , qt interval , lopinavir/ritonavir , torsades de pointes , cardiology , pharmacology , virology , covid-19 , viral load , disease , human immunodeficiency virus (hiv) , antiretroviral therapy , infectious disease (medical specialty)